ITGB1 and neoplasm: We then explored that MALAT1 may serve as “sponge ceRNA” to adjust the expression of ITGB1 and tumor growth through inhibiting the expression of miR-183 in melanoma cells, providing a new insight in the therapy of malignant melanoma.